HighMark Wealth Management’s Cytosorbents Corp CTSO Stock Holding History

HighMark Wealth Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$18.8K	–	581
2023 Q3	$18.8K	Hold	10,000	–	–	0.02%	185
2023 Q2	$35.9K	Hold	10,000	–	–	0.03%	139
2023 Q1	$33.7K	Hold	10,000	–	–	0.03%	165
2022 Q4	$15.5K	Hold	10,000	–	–	0.01%	196
2022 Q3	$14K	Hold	10,000	–	–	0.01%	197
2022 Q2	$22K	Hold	10,000	–	–	0.02%	148
2022 Q1	$32K	Hold	10,000	–	–	0.02%	131
2021 Q4	$42K	Hold	10,000	–	–	0.03%	128
2021 Q3	$81K	Hold	10,000	–	–	0.06%	89
2021 Q2	$76K	Hold	10,000	–	–	0.06%	94
2021 Q1	$87K	Hold	10,000	–	–	0.07%	74
2020 Q4	$80K	Hold	10,000	–	–	0.07%	76
2020 Q3	$80K	Hold	10,000	–	–	0.07%	76
2020 Q2	$99K	Hold	10,000	–	–	0.11%	54
2020 Q1	$77K	Hold	10,000	–	–	0.09%	53
2019 Q4	$38K	Buy	+10,000	New	+$43.6K	0.04%	94

Other funds holding CTSO

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighMark Wealth Management's CTSO Position: Q4 2023 in Review

HighMark Wealth Management sold out of Cytosorbents Corp (CTSO) in Q4 2023, closing a stake of 10,000 shares — an estimated $18.8K sold.

HighMark Wealth Management first reported a position in CTSO in Q4 2019 and held it in 16 quarters. The position peaked at $99K in Q2 2020. 54 funds tracked by Wall St. Rank hold CTSO as of Q4 2023.

HighMark Wealth Management reported no remaining Cytosorbents Corp position as of Q4 2023 after selling out during the quarter.
HighMark Wealth Management sold 10,000 Cytosorbents Corp shares in Q4 2023, an estimated $18.8K.
HighMark Wealth Management first reported a position in Cytosorbents Corp in Q4 2019 and held it in 16 quarters.
HighMark Wealth Management's Cytosorbents Corp position peaked at $99K in Q2 2020.
54 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2023.

Based on HighMark Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.